Hydroxychloroquine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Hydroxychloroquine and local guidelines before prescribing.
Mechanism
Antimalarial that interferes with lysosomal activity and toll-like receptor signalling.
Uses
SLE, rheumatoid arthritis, Sjogren syndrome, malaria prophylaxis.
Dosing
- Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
Obstetrics - Hydroxychloroquine | Raises lysosomal pH → impairs antigen presentation and Toll-like receptor signalling (reduces type I interferon) | Retinopathy (annual screening after 5 years; dose 5 mg/kg/day or less), QT prolongation, rare cardiomyopathy; safe in pregnancy — the backbone of SLE treatment
Rheumatology Anatomy Physiology Pharmacology - Stop methotrexate (1–3 months before conception per BSR); continue sulfasalazine (with folic acid 5 mg daily) and consider adding hydroxychloroquine to keep disease controlled.
Rheumatology: assessment, investigations and drugs - Hydroxychloroquine for all SLE patients unless contraindicated; aim for prednisolone 5 mg or less.
Rheumatology: Connective tissue diseases
4 more dose entries from the chapters
- 4. A 31-year-old woman with SLE (anti-Ro positive, antiphospholipid antibody negative) on hydroxychloroquine, mycophenolate and prednisolone 5 mg wants to become pregnant. Answer: Pre-pregnancy planning in SLE.
Rheumatology: Emergencies, pregnancy and other systemic diseases - Hydroxychloroquine (and chloroquine) | Retinal toxicity ("bull's-eye" maculopathy) — irreversible; risk with dose over 5 mg/kg/day (actual body weight), long duration, renal impairment, tamoxifen — annual screening (OCT and fields) after 5 years of use (after 1 year if additional risk factors — RCOphth 2020)
Ophthalmology: Anatomy Physiology and Pharmacology - 3. A 46-year-old woman with SLE has taken hydroxychloroquine 400 mg daily for 7 years. She weighs 58 kg and has eGFR 52. Answer: High risk of hydroxychloroquine retinopathy.
Ophthalmology: Anatomy Physiology and Pharmacology - Hydroxychloroquine | Retinal toxicity (bull's-eye maculopathy, permanent). Keep dose at 5 mg/kg/day or less (actual body weight). RCOphth : yearly screening (OCT and fields) after 5 years , or after 1 year if extra risk (eGFR under 60, tamoxifen, higher doses).
Ophthalmology: Neuro-ophthalmology
Side effects
Nausea, rash, headache; retinopathy with prolonged use; QT prolongation, cardiomyopathy rare.
Interactions
QT-prolonging drugs; antacids reduce absorption; digoxin levels may rise.
Contraindications and cautions
Retinopathy, QT prolongation
Monitoring
Retinal screening, ECG if risk
Pregnancy and breastfeeding
Acceptable
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive; gastric lavage early
Special advice
Baseline and annual retinal screening after 5 years; weight-based daily dose limit.
More from the textbook: uses, cautions and other points
- Other drugs: Clozapine, high-dose 5-FU (vasospasm), some antiretrovirals, hydroxychloroquine (rare restrictive cardiomyopathy with conduction disease).
Cardiology: Cardiomyopathies › 3.43 Alcohol- and Drug-related Cardiomyopathy - Drugs that can worsen myasthenia - aminoglycosides (gentamicin), fluoroquinolones (ciprofloxacin), macrolides , magnesium , beta-blockers , quinine, chloroquine and hydroxychloroquine, penicillamine, lithium, phenytoin, statins (rarely), immune checkpoint inhibitors , botulinum toxin, neuromuscular blocking drugs. Check before …
Neurology: Anatomy, Physiology and Pharmacology - Chloroquine and hydroxychloroquine.
Neurology: Neuromuscular disease - Drugs and toxins - statins , steroids, alcohol , colchicine, hydroxychloroquine, zidovudine, checkpoint inhibitors.
Neurology: Neuromuscular disease - Hydroxychloroquine for all (reduces flares).
Renal: Glomerular Disease - Hydroxychloroquine | All lupus patients; yearly eye screening after 5 years.
Renal: Glomerular Disease
Where it is discussed in the book
- Cardiology: Cardiomyopathies (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Neuromuscular disease (2 mentions)
- Renal: Glomerular Disease (4 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (2 mentions)
- Dermatology: Skin basics, eczema and psoriasis (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (6 mentions)
- Rheumatology: Connective tissue diseases (12 mentions)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (2 mentions)
- Rheumatology: Inflammatory arthritis (4 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (8 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Ear disorders (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (6 mentions)
- Ophthalmology Basics Cataract Glaucoma (1 mention)
- Ophthalmology: Retinal Visual Loss (2 mentions)
- Ophthalmology: Neuro-ophthalmology (6 mentions)
- Ophthalmology: Paediatrics (3 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Clinical Immunology: Autoimmunity, autoantibodies and complement (5 mentions)
- Integrated cardiology chapter (1 mention)
- Biochemistry: Inborn errors of metabolism and the molecular basis of disease (1 mention)